| Year |
Citation |
Score |
| 2020 |
Smith KS, Xu K, Mercer KS, Boop F, Klimo P, DeCupyere M, Grenet J, Robinson S, Dunphy P, Baker SJ, Ellison DW, Merchant TE, Upadayaya SA, Gajjar A, Wu G, ... ... Roussel MF, et al. Patient-derived orthotopic xenografts of pediatric brain tumors: a St. Jude resource. Acta Neuropathologica. PMID 32519082 DOI: 10.1007/S00401-020-02171-5 |
0.307 |
|
| 2020 |
Wijaya J, Vo BT, Liu J, Xu B, Wu G, Wang Y, Peng J, Zhang J, Janke LJ, Orr BA, Yu J, Roussel MF, Schuetz JD. An ABC transporter drives medulloblastoma pathogenesis by regulating Sonic Hedgehog signaling. Cancer Research. PMID 31948942 DOI: 10.1158/0008-5472.Can-19-2054 |
0.371 |
|
| 2020 |
Dunphy PS, Xu K, Gentry DT, He C, Mercer K, Zhu X, Smith K, Gudenas B, Robinson S, Zhang J, Kasper LH, Kwon C, Hover LD, Larson JD, Twarog N, ... ... Roussel MF, et al. Abstract 6144: St. Jude Pediatric Brain Tumor Portal: Cloud-based resource for patient-derived orthotopic xenograft (PDOX) models of pediatric high-grade glioma, ependymoma, and CNS embryonal tumors Tumor Biology. DOI: 10.1158/1538-7445.Am2020-6144 |
0.301 |
|
| 2019 |
Campagne O, Davis A, Maharaj AR, Zhong B, Stripay J, Farmer D, Roussel MF, Stewart CF. CNS penetration and pharmacodynamics of the CHK1 inhibitor prexasertib in a mouse Group 3 medulloblastoma model. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. 105106. PMID 31669383 DOI: 10.1016/J.Ejps.2019.105106 |
0.338 |
|
| 2019 |
Zhang L, He X, Liu X, Zhang F, Huang LF, Potter AS, Xu L, Zhou W, Zheng T, Luo Z, Berry KP, Pribnow A, Smith SM, Fuller C, Jones BV, ... ... Roussel MF, et al. Single-Cell Transcriptomics in Medulloblastoma Reveals Tumor-Initiating Progenitors and Oncogenic Cascades during Tumorigenesis and Relapse. Cancer Cell. PMID 31474569 DOI: 10.1016/J.Ccell.2019.07.009 |
0.367 |
|
| 2019 |
Annunziata I, van de Vlekkert D, Wolf E, Finkelstein D, Neale G, Machado E, Mosca R, Campos Y, Tillman H, Roussel MF, Andrew Weesner J, Ellen Fremuth L, Qiu X, Han MJ, Grosveld GC, et al. MYC competes with MiT/TFE in regulating lysosomal biogenesis and autophagy through an epigenetic rheostat. Nature Communications. 10: 3623. PMID 31399583 DOI: 10.1038/S41467-019-11568-0 |
0.324 |
|
| 2019 |
Wang J, Merino DM, Light N, Murphy BL, Wang YD, Guo X, Hodges AP, Chau LQ, Liu KW, Dhall G, Asgharzadeh S, Kiehna EN, Shirey RJ, Janda KD, Taylor MD, ... ... Roussel MF, et al. Myc and loss of p53 cooperate to drive formation of choroid plexus carcinoma. Cancer Research. PMID 30885981 DOI: 10.1158/0008-5472.Can-18-2565 |
0.382 |
|
| 2019 |
Jonchere B, Stripay J, Pribnow A, Zindy F, Min J, Freeman B, Shelat A, Rankovic Z, Roussel M. PDTM-02. TARGETING THE RB PATHWAY IN MEDULLOBLASTOMA Neuro-Oncology. 21: vi187-vi187. DOI: 10.1093/Neuonc/Noz175.778 |
0.323 |
|
| 2018 |
Vo BT, Kwon JA, Li C, Finkelstein D, Xu B, Orr BA, Sherr CJ, Roussel MF. Mouse medulloblastoma driven by CRISPR activation of cellular Myc. Scientific Reports. 8: 8733. PMID 29880921 DOI: 10.1038/S41598-018-24956-1 |
0.364 |
|
| 2018 |
Ganguly D, Fan M, Yang CH, Zbytek B, Finkelstein D, Roussel MF, Pfeffer LM. The critical role that STAT3 plays in glioma-initiating cells: STAT3 addiction in glioma. Oncotarget. 9: 22095-22112. PMID 29774125 DOI: 10.18632/Oncotarget.25188 |
0.388 |
|
| 2018 |
El Nagar S, Zindy F, Moens C, Martin L, Plassard D, Roussel MF, Lamonerie T, Billon N. A new genetically engineered mouse model of choroid plexus carcinoma. Biochemical and Biophysical Research Communications. PMID 29339161 DOI: 10.1016/J.Bbrc.2017.11.192 |
0.332 |
|
| 2018 |
Zuckermann M, Ismer B, Hovestadt V, Knobbe-Thomsen CB, Zapatka M, Northcott PA, Roussel MF, Reifenberger G, Lichter P, Pfister SM, Kawauchi D, Gronych J, Jones DT. Abstract 5109: Somatic CRISPR/Cas9-mediated gene editing enables versatile brain tumor modeling Cancer Research. 78: 5109-5109. DOI: 10.1158/1538-7445.Am2018-5109 |
0.361 |
|
| 2017 |
Roussel MF, Stripay JL. Epigenetic Drivers in Pediatric Medulloblastoma. Cerebellum (London, England). PMID 29178021 DOI: 10.1007/S12311-017-0899-9 |
0.314 |
|
| 2017 |
Wei L, Murphy BL, Wu G, Parker M, Easton J, Gilbertson RJ, Zhang J, Roussel MF. Exome sequencing analysis of murine medulloblastoma models identifies WDR11 as a potential tumor suppressor in Group 3 tumors. Oncotarget. 8: 64685-64697. PMID 29029386 DOI: 10.18632/Oncotarget.19642 |
0.352 |
|
| 2017 |
Fukuda Y, Wang Y, Lian S, Lynch J, Nagai S, Fanshawe B, Kandilci A, Janke LJ, Neale G, Fan Y, Sorrentino BP, Roussel MF, Grosveld G, Schuetz JD. Upregulated heme biosynthesis, an exploitable vulnerability in MYCN-driven leukemogenesis. Jci Insight. 2. PMID 28768907 DOI: 10.1172/Jci.Insight.92409 |
0.315 |
|
| 2017 |
Kawauchi D, Ogg RJ, Liu L, Shih DJH, Finkelstein D, Murphy BL, Rehg JE, Korshunov A, Calabrese C, Zindy F, Phoenix T, Kawaguchi Y, Gronych J, Gilbertson RJ, Lichter P, ... ... Roussel MF, et al. Novel MYC-driven medulloblastoma models from multiple embryonic cerebellar cells. Oncogene. PMID 28504719 DOI: 10.1038/Onc.2017.110 |
0.373 |
|
| 2017 |
Vo BT, Li C, Morgan MA, Theurillat I, Finkelstein D, Wright S, Hyle J, Smith SM, Fan Y, Wang YD, Wu G, Orr BA, Northcott PA, Shilatifard A, Sherr CJ, ... Roussel MF, et al. Inactivation of Ezh2 Upregulates Gfi1 and Drives Aggressive Myc-Driven Group 3 Medulloblastoma. Cell Reports. 18: 2907-2917. PMID 28329683 DOI: 10.1016/J.Celrep.2017.02.073 |
0.357 |
|
| 2017 |
Jones Z, Roberts J, Houke H, Roussel M, Stewart C, Panetta C. Abstract 314: Evaluation of effective drug combinations of sonidegib and ribociclib for treatment of Sonic hedgehog medulloblastoma using mathematical models of the cell cycle and Hedgehog pathways Cancer Research. 77: 314-314. DOI: 10.1158/1538-7445.Am2017-314 |
0.333 |
|
| 2016 |
Phoenix TN, Patmore DM, Boop S, Boulos N, Jacus MO, Patel YT, Roussel MF, Finkelstein D, Goumnerova L, Perreault S, Wadhwa E, Cho YJ, Stewart CF, Gilbertson RJ. Medulloblastoma Genotype Dictates Blood Brain Barrier Phenotype. Cancer Cell. PMID 27050100 DOI: 10.1016/J.Ccell.2016.03.002 |
0.317 |
|
| 2016 |
Vo BT, Wolf E, Kawauchi D, Gebhardt A, Rehg JE, Finkelstein D, Walz S, Murphy BL, Youn YH, Han YG, Eilers M, Roussel MF. The Interaction of Myc with Miz1 Defines Medulloblastoma Subgroup Identity. Cancer Cell. 29: 5-16. PMID 26766587 DOI: 10.1016/J.Ccell.2015.12.003 |
0.305 |
|
| 2016 |
Zuckermann M, Hovestadt V, Knobbe-Thomsen CB, Zapatka M, Northcott PA, Schramm K, Belic J, Jones DT, Tschida B, Moriarity B, Largaespada D, Roussel MF, Korshunov A, Reifenberger G, Pfister SM, et al. PCM-15SOMATIC CRISPR/Cas9-MEDIATED TUMOR SUPPRESSOR DISRUPTION ENABLES VERSATILE BRAIN TUMOR MODELING Neuro-Oncology. 18: iii142.2-iii142. DOI: 10.1093/Neuonc/Now080.15 |
0.311 |
|
| 2015 |
Morfouace M, Nimmervoll B, Boulos N, Patel YT, Shelat A, Freeman BB, Robinson GW, Wright K, Gajjar A, Stewart CF, Gilbertson RJ, Roussel MF. Preclinical studies of 5-fluoro-2'-deoxycytidine and tetrahydrouridine in pediatric brain tumors. Journal of Neuro-Oncology. PMID 26518542 DOI: 10.1007/S11060-015-1965-0 |
0.328 |
|
| 2015 |
Zuckermann M, Hovestadt V, Knobbe-Thomsen CB, Zapatka M, Northcott PA, Schramm K, Belic J, Jones DT, Tschida B, Moriarity B, Largaespada D, Roussel MF, Korshunov A, Reifenberger G, Pfister SM, et al. Somatic CRISPR/Cas9-mediated tumour suppressor disruption enables versatile brain tumour modelling. Nature Communications. 6: 7391. PMID 26067104 DOI: 10.1038/Ncomms8391 |
0.304 |
|
| 2015 |
Penas C, Govek EE, Fang Y, Ramachandran V, Daniel M, Wang W, Maloof ME, Rahaim RJ, Bibian M, Kawauchi D, Finkelstein D, Han JL, Long J, Li B, Robbins DJ, ... ... Roussel MF, et al. Casein kinase 1δ is an APC/C(Cdh1) substrate that regulates cerebellar granule cell neurogenesis. Cell Reports. 11: 249-60. PMID 25843713 DOI: 10.1016/J.Celrep.2015.03.016 |
0.349 |
|
| 2015 |
Zuckermann M, Hovestadt V, Knobbe-Thomsen CB, Zapatka M, Northcott PA, Schramm K, Belic J, Jones DTW, Tschida B, Moriarity B, Largaespada D, Roussel MF, Korshunov A, Reifenberger G, Pfister SM, et al. Abstract PR02: Somatic CRISPR/Cas9-mediated tumor suppressor disruption enables versatile brain tumor modeling Brain. 75. DOI: 10.1158/1538-7445.Brain15-Pr02 |
0.367 |
|
| 2015 |
Morfouace M, Patel Y, Shelat A, Kawauchi D, Robinson GW, Guy K, Gilbertson RJ, Stewart C, Gajjar A, Roussel MF. Abstract IA21: Pediatric medulloblastoma: Drug screens and preclinical studies Brain. 75. DOI: 10.1158/1538-7445.Brain15-Ia21 |
0.348 |
|
| 2014 |
Lindsey JC, Kawauchi D, Schwalbe EC, Solecki DJ, Selby MP, McKinnon PJ, Olson JM, Hayden JT, Grundy RG, Ellison DW, Williamson D, Bailey S, Roussel MF, Clifford SC. Cross-species epigenetics identifies a critical role for VAV1 in SHH subgroup medulloblastoma maintenance. Oncogene. PMID 25531316 DOI: 10.1038/Onc.2014.405 |
0.33 |
|
| 2014 |
Cox BC, Dearman JA, Brancheck J, Zindy F, Roussel MF, Zuo J. Generation of Atoh1-rtTA transgenic mice: a tool for inducible gene expression in hair cells of the inner ear. Scientific Reports. 4: 6885. PMID 25363458 DOI: 10.1038/Srep06885 |
0.334 |
|
| 2014 |
Doherty JR, Nilsson LM, Kuliyev E, Zhu H, Matthew R, Cleveland JL, Mead PE, Roussel MF. Embryonic Expression and Function of the Xenopus Ink4d Cyclin D-Dependent Kinase Inhibitor. Cell & Developmental Biology. 3. PMID 25309971 DOI: 10.4172/2168-9296.1000133 |
0.354 |
|
| 2014 |
Vo BT, Wolf E, Kawauchi D, Rehg J, Finkelstein D, Murphy B, Eilers M, Roussel MF. Abstract 2977: Myc and Miz1 in medulloblastoma Cancer Research. 74: 2977-2977. DOI: 10.1158/1538-7445.Am2014-2977 |
0.353 |
|
| 2014 |
Wei L, Murphy BL, Parker M, Wu G, Easton J, Roussel MF, Zhang J. Ge-40Comparative Genomic Analyses Identifies Non-Silent Mutations Present In Both Murine And Human Medulloblastoma Neuro-Oncology. 16. DOI: 10.1093/Neuonc/Nou256.39 |
0.34 |
|
| 2014 |
Penas C, Zhang M, Clarke J, Stathias V, Roussel M, Hatten M, Ayad N. Cb-14Genomic Approaches To Identify Coding And Noncoding Rna Targets In Medulloblastoma. Neuro-Oncology. 16. DOI: 10.1093/Neuonc/Nou241.13 |
0.359 |
|
| 2013 |
Anne SL, Govek EE, Ayrault O, Kim JH, Zhu X, Murphy DA, Van Aelst L, Roussel MF, Hatten ME. WNT3 inhibits cerebellar granule neuron progenitor proliferation and medulloblastoma formation via MAPK activation. Plos One. 8: e81769. PMID 24303070 DOI: 10.1371/Journal.Pone.0081769 |
0.346 |
|
| 2013 |
Roussel MF, Robinson GW. Role of MYC in Medulloblastoma. Cold Spring Harbor Perspectives in Medicine. 3. PMID 24186490 DOI: 10.1101/Cshperspect.A014308 |
0.343 |
|
| 2013 |
Wolf E, Gebhardt A, Kawauchi D, Walz S, von Eyss B, Wagner N, Renninger C, Krohne G, Asan E, Roussel MF, Eilers M. Miz1 is required to maintain autophagic flux. Nature Communications. 4: 2535. PMID 24088869 DOI: 10.1038/Ncomms3535 |
0.364 |
|
| 2013 |
Zhao M, Gupta V, Raj L, Roussel M, Bei M. A Network of Transcription Factors Operates during Early Tooth Morphogenesis Molecular and Cellular Biology. 33: 3099-3112. PMID 23754753 DOI: 10.1128/Mcb.00524-13 |
0.314 |
|
| 2013 |
Vrijens K, Lin W, Cui J, Farmer D, Low J, Pronier E, Zeng FY, Shelat AA, Guy K, Taylor MR, Chen T, Roussel MF. Identification of small molecule activators of BMP signaling. Plos One. 8: e59045. PMID 23527084 DOI: 10.1371/Journal.Pone.0059045 |
0.305 |
|
| 2013 |
Turner DC, Freeman BB, Jacus MO, Morfouace M, Throm SL, Vuppala PK, Roussel M, Gajjar A, Stewart CF. Abstract 2749: Gemcitabine (GEM), a drug with clinical activity against pediatric solid tumors, demonstrates satisfactory CNS penetration in a preclinical murine medulloblastoma (MB) model. Cancer Research. 73: 2749-2749. DOI: 10.1158/1538-7445.Am2013-2749 |
0.304 |
|
| 2012 |
Liu Z, Dearman JA, Cox BC, Walters BJ, Zhang L, Ayrault O, Zindy F, Gan L, Roussel MF, Zuo J. Age-dependent in vivo conversion of mouse cochlear pillar and Deiters' cells to immature hair cells by Atoh1 ectopic expression. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 6600-10. PMID 22573682 DOI: 10.1523/Jneurosci.0818-12.2012 |
0.314 |
|
| 2012 |
Kawauchi D, Robinson G, Uziel T, Gibson P, Rehg J, Gao C, Finkelstein D, Qu C, Pounds S, Ellison DW, Gilbertson RJ, Roussel MF. A mouse model of the most aggressive subgroup of human medulloblastoma. Cancer Cell. 21: 168-80. PMID 22340591 DOI: 10.1016/J.Ccr.2011.12.023 |
0.361 |
|
| 2012 |
Kawauchi D, Robinson G, Uziel T, Elisson DW, Gilbertson RJ, Roussel MF. Abstract SY10-03: Cell of origin in pediatric medulloblastomas Cancer Research. 72. DOI: 10.1158/1538-7445.Am2012-Sy10-03 |
0.363 |
|
| 2012 |
Kawauchi D, Robinson G, Uziel T, Gibson P, Rehg J, Gao C, Finkelstein D, Qu C, Pounds S, Ellison DW, Gilbertson RJ, Roussel MF. Abstract 1434: A mouse model of the most aggressive subgroup of human medulloblastoma Cancer Research. 72: 1434-1434. DOI: 10.1158/1538-7445.Am2012-1434 |
0.378 |
|
| 2011 |
Gil-Perotin S, Haines JD, Kaur J, Marin-Husstege M, Spinetta MJ, Kim KH, Duran-Moreno M, Schallert T, Zindy F, Roussel MF, Garcia-Verdugo JM, Casaccia P. Roles of p53 and p27(Kip1) in the regulation of neurogenesis in the murine adult subventricular zone. The European Journal of Neuroscience. 34: 1040-52. PMID 21899604 DOI: 10.1111/J.1460-9568.2011.07836.X |
0.408 |
|
| 2011 |
Wang Y, Fisher JC, Mathew R, Ou L, Otieno S, Sublet J, Xiao L, Chen J, Roussel MF, Kriwacki RW. Intrinsic disorder mediates the diverse regulatory functions of the Cdk inhibitor p21. Nature Chemical Biology. 7: 214-21. PMID 21358637 DOI: 10.1038/Nchembio.536 |
0.318 |
|
| 2011 |
Hatten ME, Roussel MF. Development and cancer of the cerebellum. Trends in Neurosciences. 34: 134-42. PMID 21315459 DOI: 10.1016/J.Tins.2011.01.002 |
0.333 |
|
| 2011 |
Roussel MF, Hatten ME. Cerebellum development and medulloblastoma. Current Topics in Developmental Biology. 94: 235-82. PMID 21295689 DOI: 10.1016/B978-0-12-380916-2.00008-5 |
0.323 |
|
| 2011 |
Trikha P, Sharma N, Opavsky R, Reyes A, Pena C, Ostrowski MC, Roussel MF, Leone G. E2f1-3 are critical for myeloid development. The Journal of Biological Chemistry. 286: 4783-95. PMID 21115501 DOI: 10.1074/Jbc.M110.182733 |
0.359 |
|
| 2011 |
Roussel M. p27(Kip1) enforces maintenance of quiescence in the mammalian ear and the pituitary gland. Cell Cycle. 10: 2617-2618. DOI: 10.4161/Cc.10.16.16544 |
0.325 |
|
| 2011 |
Vrijens K, Lin W, Cui J, Shelat A, Taylor M, Guy KR, Chen T, Roussel MF. Abstract 4522: Identification of small molecule agonists/activators of BMP-2, 4, 7 signaling Cancer Research. 71: 4522-4522. DOI: 10.1158/1538-7445.Am2011-4522 |
0.341 |
|
| 2011 |
Lindsey JC, Schwalbe EC, Kawauchi D, Olson JM, McKinnon PJ, Gilbertson RJ, Roussel MF, Ellison DW, Bailey S, Clifford SC. Abstract 3449: Epigenomics identifies conserved DNA methylation events associated with medulloblastoma development in humans and mice Cancer Research. 71: 3449-3449. DOI: 10.1158/1538-7445.Am2011-3449 |
0.328 |
|
| 2011 |
Gibson P, Tong Y, Robinson G, Poppleton H, Thompson MC, Currle DS, Eden C, Hogg TL, Finkelstein D, Pounds S, Patay Z, Scoggins M, Pei Y, Ogg R, Lee Y, ... ... Roussel MF, et al. Abstract 3448: Subtypes of medulloblastoma have distinct developmental origins Cancer Research. 71: 3448-3448. DOI: 10.1158/1538-7445.Am2011-3448 |
0.373 |
|
| 2011 |
Kawauchi D, Robinson G, Uziel T, Rehg J, Zindy F, Qu C, Gajjar A, Gilbertson RJ, Roussel MF. Abstract 3444: Enforced expression of MycN and C-Myc induces different medulloblastoma subtypes Cancer Research. 71: 3444-3444. DOI: 10.1158/1538-7445.Am2011-3444 |
0.374 |
|
| 2010 |
Gibson P, Tong Y, Robinson G, Thompson MC, Currle DS, Eden C, Kranenburg TA, Hogg T, Poppleton H, Martin J, Finkelstein D, Pounds S, Weiss A, Patay Z, Scoggins M, ... ... Roussel MF, et al. Subtypes of medulloblastoma have distinct developmental origins. Nature. 468: 1095-9. PMID 21150899 DOI: 10.1038/Nature09587 |
0.335 |
|
| 2010 |
Roussel MF. New concepts in organ site research on medulloblastoma: genetics and genomics. Future Oncology (London, England). 6: 1229-31. PMID 20799868 DOI: 10.2217/Fon.10.86 |
0.323 |
|
| 2010 |
Ayrault O, Zhao H, Zindy F, Qu C, Sherr CJ, Roussel MF. Atoh1 inhibits neuronal differentiation and collaborates with Gli1 to generate medulloblastoma-initiating cells. Cancer Research. 70: 5618-27. PMID 20516124 DOI: 10.1158/0008-5472.Can-09-3740 |
0.363 |
|
| 2009 |
Ayrault O, Godeny MD, Dillon C, Zindy F, Fitzgerald P, Roussel MF, Beere HM. Inhibition of Hsp90 via 17-DMAG induces apoptosis in a p53-dependent manner to prevent medulloblastoma. Proceedings of the National Academy of Sciences of the United States of America. 106: 17037-42. PMID 19805107 DOI: 10.1073/Pnas.0902880106 |
0.415 |
|
| 2009 |
Ayrault O, Zindy F, Rehg J, Sherr CJ, Roussel MF. Two tumor suppressors, p27Kip1 and patched-1, collaborate to prevent medulloblastoma. Molecular Cancer Research : McR. 7: 33-40. PMID 19147535 DOI: 10.1158/1541-7786.Mcr-08-0369 |
0.414 |
|
| 2008 |
Forget A, Ayrault O, den Besten W, Kuo ML, Sherr CJ, Roussel MF. Differential post-transcriptional regulation of two Ink4 proteins, p18 Ink4c and p19 Ink4d. Cell Cycle (Georgetown, Tex.). 7: 3737-46. PMID 19029828 DOI: 10.4161/Cc.7.23.7187 |
0.383 |
|
| 2008 |
Reilly KM, Rubin JB, Gilbertson RJ, Garbow JR, Roussel MF, Gutmann DH. Rethinking brain tumors: the fourth Mouse Models of Human Cancers Consortium nervous system tumors workshop. Cancer Research. 68: 5508-11. PMID 18632599 DOI: 10.1158/0008-5472.Can-08-0703 |
0.361 |
|
| 2008 |
Zhao H, Ayrault O, Zindy F, Kim JH, Roussel MF. Post-transcriptional down-regulation of Atoh1/Math1 by bone morphogenic proteins suppresses medulloblastoma development. Genes & Development. 22: 722-7. PMID 18347090 DOI: 10.1101/Gad.1636408 |
0.347 |
|
| 2007 |
Zindy F, Uziel T, Ayrault O, Calabrese C, Valentine M, Rehg JE, Gilbertson RJ, Sherr CJ, Roussel MF. Genetic alterations in mouse medulloblastomas and generation of tumors de novo from primary cerebellar granule neuron precursors. Cancer Research. 67: 2676-84. PMID 17363588 DOI: 10.1158/0008-5472.Can-06-3418 |
0.4 |
|
| 2007 |
Laine H, Doetzlhofer A, Mantela J, Ylikoski J, Laiho M, Roussel MF, Segil N, Pirvola U. p19(Ink4d) and p21(Cip1) collaborate to maintain the postmitotic state of auditory hair cells, their codeletion leading to DNA damage and p53-mediated apoptosis. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 1434-44. PMID 17287518 DOI: 10.1523/Jneurosci.4956-06.2007 |
0.375 |
|
| 2007 |
Nilsson LM, Keller UB, Yang C, Nilsson JA, Cleveland JL, Roussel MF. Ink4c is dispensable for tumor suppression in Myc-induced B-cell lymphomagenesis Oncogene. 26: 2833-2839. PMID 17099725 DOI: 10.1038/Sj.Onc.1210104 |
0.371 |
|
| 2006 |
Williams RT, Roussel MF, Sherr CJ. Arf gene loss enhances oncogenicity and limits imatinib response in mouse models of Bcr-Abl-induced acute lymphoblastic leukemia. Proceedings of the National Academy of Sciences of the United States of America. 103: 6688-93. PMID 16618932 DOI: 10.1073/Pnas.0602030103 |
0.388 |
|
| 2006 |
Uziel T, Zindy F, Sherr CJ, Roussel MF. The CDK inhibitor p18Ink4c is a tumor suppressor in medulloblastoma. Cell Cycle (Georgetown, Tex.). 5: 363-5. PMID 16479172 DOI: 10.4161/Cc.5.4.2475 |
0.463 |
|
| 2006 |
Gil-Perotin S, Marin-Husstege M, Li J, Soriano-Navarro M, Zindy F, Roussel MF, Garcia-Verdugo JM, Casaccia-Bonnefil P. Loss of p53 induces changes in the behavior of subventricular zone cells: implication for the genesis of glial tumors. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 1107-16. PMID 16436596 DOI: 10.1523/Jneurosci.3970-05.2006 |
0.414 |
|
| 2005 |
Sherr CJ, Bertwistle D, DEN Besten W, Kuo ML, Sugimoto M, Tago K, Williams RT, Zindy F, Roussel MF. p53-Dependent and -independent functions of the Arf tumor suppressor. Cold Spring Harbor Symposia On Quantitative Biology. 70: 129-37. PMID 16869746 DOI: 10.1101/Sqb.2005.70.004 |
0.451 |
|
| 2005 |
Uziel T, Zindy F, Xie S, Lee Y, Forget A, Magdaleno S, Rehg JE, Calabrese C, Solecki D, Eberhart CG, Sherr SE, Plimmer S, Clifford SC, Hatten ME, McKinnon PJ, ... ... Roussel MF, et al. The tumor suppressors Ink4c and p53 collaborate independently with Patched to suppress medulloblastoma formation. Genes & Development. 19: 2656-67. PMID 16260494 DOI: 10.1101/Gad.1368605 |
0.45 |
|
| 2005 |
Williams RT, Roussel MF, Sherr CJ. Genetic Interaction of the BCR-ABL Oncogene and the ARF Tumor Suppressor in Ph+ Lymphoid Leukemia. Blood. 106: 240-240. DOI: 10.1182/Blood.V106.11.240.240 |
0.413 |
|
| 2004 |
Bertwistle D, Zindy F, Sherr CJ, Roussel MF. Monoclonal antibodies to the mouse p19(Arf) tumor suppressor protein. Hybridoma and Hybridomics. 23: 293-300. PMID 15672607 DOI: 10.1089/Hyb.2004.23.293 |
0.343 |
|
| 2004 |
Kuo ML, den Besten W, Bertwistle D, Roussel MF, Sherr CJ. N-terminal polyubiquitination and degradation of the Arf tumor suppressor. Genes & Development. 18: 1862-74. PMID 15289458 DOI: 10.1101/Gad.1213904 |
0.344 |
|
| 2004 |
Wrobel CN, Debnath J, Lin E, Beausoleil S, Roussel MF, Brugge JS. Autocrine CSF-1R activation promotes Src-dependent disruption of mammary epithelial architecture. The Journal of Cell Biology. 165: 263-73. PMID 15117969 DOI: 10.1083/Jcb.200309102 |
0.312 |
|
| 2004 |
Yokota T, Matsuzaki Y, Miyazawa K, Zindy F, Roussel MF, Sakai T. Histone deacetylase inhibitors activate INK4d gene through Sp1 site in its promoter. Oncogene. 23: 5340-9. PMID 15107822 DOI: 10.1038/Sj.Onc.1207689 |
0.395 |
|
| 2003 |
Zindy F, Williams RT, Baudino TA, Rehg JE, Skapek SX, Cleveland JL, Roussel MF, Sherr CJ. Arf tumor suppressor promoter monitors latent oncogenic signals in vivo. Proceedings of the National Academy of Sciences of the United States of America. 100: 15930-5. PMID 14665695 DOI: 10.1073/Pnas.2536808100 |
0.41 |
|
| 2003 |
Zindy F, Nilsson LM, Nguyen L, Meunier C, Smeyne RJ, Rehg JE, Eberhart C, Sherr CJ, Roussel MF. Hemangiosarcomas, medulloblastomas, and other tumors in Ink4c/p53-null mice. Cancer Research. 63: 5420-7. PMID 14500377 |
0.304 |
|
| 2003 |
Baudino TA, Maclean KH, Brennan J, Parganas E, Yang C, Aslanian A, Lees JA, Sherr CJ, Roussel MF, Cleveland JL. Myc-mediated proliferation and lymphomagenesis, but not apoptosis, are compromised by E2f1 loss. Molecular Cell. 11: 905-14. PMID 12718877 DOI: 10.1016/S1097-2765(03)00102-3 |
0.42 |
|
| 2003 |
Chen P, Zindy F, Abdala C, Liu F, Li X, Roussel MF, Segil N. Progressive hearing loss in mice lacking the cyclin-dependent kinase inhibitor Ink4d. Nature Cell Biology. 5: 422-6. PMID 12717441 DOI: 10.1038/Ncb976 |
0.346 |
|
| 2003 |
Sugimoto M, Kuo ML, Roussel MF, Sherr CJ. Nucleolar Arf tumor suppressor inhibits ribosomal RNA processing. Molecular Cell. 11: 415-24. PMID 12620229 DOI: 10.1016/S1097-2765(03)00057-1 |
0.41 |
|
| 2003 |
Kuo ML, Duncavage EJ, Mathew R, den Besten W, Pei D, Naeve D, Yamamoto T, Cheng C, Sherr CJ, Roussel MF. Arf induces p53-dependent and -independent antiproliferative genes. Cancer Research. 63: 1046-53. PMID 12615721 |
0.317 |
|
| 2002 |
Roussel MF. p53: regular or super? Cancer Cell. 2: 434-5. PMID 12498711 DOI: 10.1016/S1535-6108(02)00216-7 |
0.35 |
|
| 2002 |
Cunningham JJ, Levine EM, Zindy F, Goloubeva O, Roussel MF, Smeyne RJ. The cyclin-dependent kinase inhibitors p19(Ink4d) and p27(Kip1) are coexpressed in select retinal cells and act cooperatively to control cell cycle exit. Molecular and Cellular Neurosciences. 19: 359-74. PMID 11906209 DOI: 10.1006/Mcne.2001.1090 |
0.397 |
|
| 2001 |
Eischen CM, Roussel MF, Korsmeyer SJ, Cleveland JL. Bax loss impairs Myc-induced apoptosis and circumvents the selection of p53 mutations during Myc-mediated lymphomagenesis. Molecular and Cellular Biology. 21: 7653-62. PMID 11604501 DOI: 10.1128/Mcb.21.22.7653-7662.2001 |
0.397 |
|
| 2001 |
Randle DH, Zindy F, Sherr CJ, Roussel MF. Differential effects of p19(Arf) and p16(Ink4a) loss on senescence of murine bone marrow-derived preB cells and macrophages. Proceedings of the National Academy of Sciences of the United States of America. 98: 9654-9. PMID 11481442 DOI: 10.1073/Pnas.171217498 |
0.769 |
|
| 2001 |
Eischen CM, Woo D, Roussel MF, Cleveland JL. Apoptosis triggered by Myc-induced suppression of Bcl-X(L) or Bcl-2 is bypassed during lymphomagenesis. Molecular and Cellular Biology. 21: 5063-70. PMID 11438662 DOI: 10.1128/Mcb.21.15.5063-5070.2001 |
0.302 |
|
| 2001 |
Drissi R, Zindy F, Roussel MF, Cleveland JL. c-Myc-mediated regulation of telomerase activity is disabled in immortalized cells. The Journal of Biological Chemistry. 276: 29994-30001. PMID 11402027 DOI: 10.1074/Jbc.M101899200 |
0.403 |
|
| 2001 |
Zindy F, den Besten W, Chen B, Rehg JE, Latres E, Barbacid M, Pollard JW, Sherr CJ, Cohen PE, Roussel MF. Control of spermatogenesis in mice by the cyclin D-dependent kinase inhibitors p18(Ink4c) and p19(Ink4d). Molecular and Cellular Biology. 21: 3244-55. PMID 11287627 DOI: 10.1128/Mcb.21.9.3244-3255.2001 |
0.352 |
|
| 2000 |
Buijs A, van Rompaey L, Molijn AC, Davis JN, Vertegaal AC, Potter MD, Adams C, van Baal S, Zwarthoff EC, Roussel MF, Grosveld GC. The MN1-TEL fusion protein, encoded by the translocation (12;22)(p13;q11) in myeloid leukemia, is a transcription factor with transforming activity. Molecular and Cellular Biology. 20: 9281-93. PMID 11094079 DOI: 10.1128/Mcb.20.24.9281-9293.2000 |
0.311 |
|
| 2000 |
Weber JD, Jeffers JR, Rehg JE, Randle DH, Lozano G, Roussel MF, Sherr CJ, Zambetti GP. p53-independent functions of the p19(ARF) tumor suppressor. Genes & Development. 14: 2358-65. PMID 10995391 DOI: 10.1101/Gad.827300 |
0.77 |
|
| 2000 |
Groth A, Weber JD, Willumsen BM, Sherr CJ, Roussel MF. Oncogenic Ras induces p19ARF and growth arrest in mouse embryo fibroblasts lacking p21Cip1 and p27Kip1 without activating cyclin D-dependent kinases. The Journal of Biological Chemistry. 275: 27473-80. PMID 10842176 DOI: 10.1074/Jbc.M003417200 |
0.404 |
|
| 2000 |
O'Farrell AM, Parry DA, Zindy F, Roussel MF, Lees E, Moore KW, Mui AL. Stat3-dependent induction of p19INK4D by IL-10 contributes to inhibition of macrophage proliferation. Journal of Immunology (Baltimore, Md. : 1950). 164: 4607-15. PMID 10779764 DOI: 10.4049/Jimmunol.164.9.4607 |
0.305 |
|
| 2000 |
Weber JD, Kuo ML, Bothner B, DiGiammarino EL, Kriwacki RW, Roussel MF, Sherr CJ. Cooperative signals governing ARF-mdm2 interaction and nucleolar localization of the complex. Molecular and Cellular Biology. 20: 2517-28. PMID 10713175 DOI: 10.1128/Mcb.20.7.2517-2528.2000 |
0.372 |
|
| 2000 |
Zindy F, van Deursen J, Grosveld G, Sherr CJ, Roussel MF. INK4d-deficient mice are fertile despite testicular atrophy. Molecular and Cellular Biology. 20: 372-8. PMID 10594039 DOI: 10.1128/Mcb.20.1.372-378.2000 |
0.432 |
|
| 2000 |
Sexl V, Piekorz R, Moriggl R, Rohrer J, Brown MP, Bunting KD, Rothammer K, Roussel MF, Ihle JN. Stat5a/b contribute to interleukin 7-induced B-cell precursor expansion, but abl- and bcr/abl-induced transformation are independent of stat5. Blood. 96: 2277-2283. DOI: 10.1182/Blood.V96.6.2277.H8002277_2277_2283 |
0.319 |
|
| 2000 |
Inoue K, Wen R, Rehg JE, Adachi M, Cleveland JL, Roussel MF, Sherr CJ. Disruption of the ARF transcriptional activator DMP1 facilitates cell immortalization, Ras transformation, and tumorigenesis Genes & Development. 14: 1797-1809. DOI: 10.1101/Gad.14.14.1797 |
0.429 |
|
| 1999 |
Weber JD, Taylor LJ, Roussel MF, Sherr CJ, Bar-Sagi D. Nucleolar Arf sequesters Mdm2 and activates p53. Nature Cell Biology. 1: 20-6. PMID 10559859 DOI: 10.1038/8991 |
0.369 |
|
| 1999 |
Zindy F, Cunningham JJ, Sherr CJ, Jogal S, Smeyne RJ, Roussel MF. Postnatal neuronal proliferation in mice lacking Ink4d and Kip1 inhibitors of cyclin-dependent kinases. Proceedings of the National Academy of Sciences of the United States of America. 96: 13462-7. PMID 10557343 DOI: 10.1073/Pnas.96.23.13462 |
0.347 |
|
| 1999 |
Eischen CM, Weber JD, Roussel MF, Sherr CJ, Cleveland JL. Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis. Genes & Development. 13: 2658-69. PMID 10541552 DOI: 10.1101/Gad.13.20.2658 |
0.441 |
|
| 1999 |
Roussel MF. The INK4 family of cell cycle inhibitors in cancer. Oncogene. 18: 5311-5317. PMID 10498883 DOI: 10.1038/Sj.Onc.1202998 |
0.425 |
|
| 1999 |
Inoue K, Roussel MF, Sherr CJ. Induction of ARF tumor suppressor gene expression and cell cycle arrest by transcription factor DMP1. Proceedings of the National Academy of Sciences of the United States of America. 96: 3993-8. PMID 10097151 DOI: 10.1073/Pnas.96.7.3993 |
0.423 |
|
| 1999 |
Bodner SM, Naeve CW, Rakestraw KM, Jones BG, Valentine VA, Valentine MB, Luthardt FW, Willman CL, Raimondi SC, Downing JR, Roussel MF, Sherr CJ, Look AT. Cloning and chromosomal localization of the gene encoding human cyclin D-binding Myb-like protein (hDMP1). Gene. 229: 223-8. PMID 10095122 DOI: 10.1016/S0378-1119(98)00591-5 |
0.32 |
|
| 1999 |
Cheng M, Olivier P, Diehl JA, Fero M, Roussel MF, Roberts JM, Sherr CJ. The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts. The Embo Journal. 18: 1571-83. PMID 10075928 DOI: 10.1093/Emboj/18.6.1571 |
0.363 |
|
| 1999 |
Cheng M, Wang D, Roussel MF. Expression of c-Myc in response to colony-stimulating factor-1 requires mitogen-activated protein kinase kinase-1. Journal of Biological Chemistry. 274: 6553-6558. PMID 10037749 DOI: 10.1074/Jbc.274.10.6553 |
0.337 |
|
| 1999 |
Sexl V, Diehl JA, Sherr CJ, Ashmun R, Beach D, Roussel MF. A rate limiting function of cdc25A for S phase entry inversely correlates with tyrosine dephosphorylation of Cdk2. Oncogene. 18: 573-82. PMID 9989807 DOI: 10.1038/Sj.Onc.1202362 |
0.342 |
|
| 1999 |
Gómez Lahoz E, Liegeois NJ, Zhang P, Engelman JA, Horner J, Silverman A, Burde R, Roussel MF, Sherr CJ, Elledge SJ, DePinho RA. Cyclin D- and E-dependent kinases and the p57(KIP2) inhibitor: cooperative interactions in vivo. Molecular and Cellular Biology. 19: 353-63. PMID 9858559 DOI: 10.1128/Mcb.19.1.353 |
0.359 |
|
| 1998 |
de Stanchina E, McCurrach ME, Zindy F, Shieh SY, Ferbeyre G, Samuelson AV, Prives C, Roussel MF, Sherr CJ, Lowe SW. E1A signaling to p53 involves the p19(ARF) tumor suppressor. Genes & Development. 12: 2434-42. PMID 9694807 DOI: 10.1101/Gad.12.15.2434 |
0.408 |
|
| 1998 |
Zindy F, Eischen CM, Randle DH, Kamijo T, Cleveland JL, Sherr CJ, Roussel MF. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes & Development. 12: 2424-33. PMID 9694806 DOI: 10.1101/Gad.12.15.2424 |
0.777 |
|
| 1998 |
Kamijo T, Weber JD, Zambetti G, Zindy F, Roussel MF, Sherr CJ. Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2. Proceedings of the National Academy of Sciences of the United States of America. 95: 8292-7. PMID 9653180 DOI: 10.1073/Pnas.95.14.8292 |
0.405 |
|
| 1998 |
Roussel MF. Key effectors of signal transduction and G1 progression. Advances in Cancer Research. 74: 1-24. PMID 9561265 DOI: 10.1016/S0065-230X(08)60763-0 |
0.338 |
|
| 1998 |
Cheng M, Sexl V, Sherr CJ, Roussel MF. Assembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase kinase (MEK1). Proceedings of the National Academy of Sciences of the United States of America. 95: 1091-6. PMID 9448290 DOI: 10.1073/Pnas.95.3.1091 |
0.356 |
|
| 1998 |
Altura RA, Inukai T, Ashmun RA, Zambetti GP, Roussel MF, Look AT. The Chimeric E2A-HLF Transcription Factor Abrogates p53-Induced Apoptosis in Myeloid Leukemia Cells Blood. 92: 1397-1405. DOI: 10.1182/Blood.V92.4.1397.416K19_1397_1405 |
0.398 |
|
| 1997 |
Kamijo T, Zindy F, Roussel MF, Quelle DE, Downing JR, Ashmun RA, Grosveld G, Sherr CJ. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell. 91: 649-59. PMID 9393858 DOI: 10.1016/S0092-8674(00)80452-3 |
0.435 |
|
| 1997 |
Davis JN, Rock CO, Cheng M, Watson JB, Ashmun RA, Kirk H, Kay RJ, Roussel MF. Complementation of growth factor receptor-dependent mitogenic signaling by a truncated type I phosphatidylinositol 4-phosphate 5-kinase. Molecular and Cellular Biology. 17: 7398-406. PMID 9372970 DOI: 10.1128/Mcb.17.12.7398 |
0.332 |
|
| 1997 |
Zindy F, Quelle DE, Roussel MF, Sherr CJ. Expression of the p16INK4a tumor suppressor versus other INK4 family members during mouse development and aging. Oncogene. 15: 203-11. PMID 9244355 DOI: 10.1038/Sj.Onc.1201178 |
0.382 |
|
| 1997 |
Roussel MF. Regulation of cell cycle entry and G1 progression by CSF‐1 Molecular Reproduction and Development. 46: 11-18. PMID 8981358 DOI: 10.1002/(Sici)1098-2795(199701)46:1<11::Aid-Mrd3>3.0.Co;2-U |
0.369 |
|
| 1997 |
Adachi M, Roussel MF, Havenith K, Sherr CJ. Features of Macrophage Differentiation Induced by p19INK4d, a Specific Inhibitor of Cyclin D–Dependent Kinases Blood. 90: 126-137. DOI: 10.1182/Blood.V90.1.126 |
0.347 |
|
| 1996 |
Roussel MF, Ashmun RA, Sherr CJ, Eisenman RN, Ayer DE. Inhibition of cell proliferation by the Mad1 transcriptional repressor. Molecular and Cellular Biology. 16: 2796-801. PMID 8649388 DOI: 10.1128/Mcb.16.6.2796 |
0.367 |
|
| 1995 |
Hirai H, Roussel MF, Kato JY, Ashmun RA, Sherr CJ. Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D- dependent kinases CDK4 and CDK6 Molecular and Cellular Biology. 15: 2672-2681. PMID 7739547 DOI: 10.1128/Mcb.15.5.2672 |
0.378 |
|
| 1995 |
Roussel MF, Theodoras AM, Pagano M, Sherr CJ. Rescue of defective mitogenic signaling by D-type cyclins Proceedings of the National Academy of Sciences of the United States of America. 92: 6837-6841. PMID 7624328 DOI: 10.1073/Pnas.92.15.6837 |
0.337 |
|
| 1994 |
Roussel MF. Signal transduction by the macrophage-colony-stimulating factor receptor (CSF-1R). Journal of Cell Science. 1994: 105-108. PMID 7883784 DOI: 10.1242/Jcs.1994.Supplement_18.15 |
0.352 |
|
| 1993 |
Quelle DE, Ashmun RA, Shurtleff SA, Kato JY, Bar-Sagi D, Roussel MF, Sherr CJ. Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts Genes and Development. 7: 1559-1571. PMID 8339933 DOI: 10.1101/Gad.7.8.1559 |
0.317 |
|
| 1992 |
Matsushime H, Ewen ME, Strom DK, Kato JY, Hanks SK, Roussel MF, Sherr CJ. Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins Cell. 71: 323-334. PMID 1423597 DOI: 10.1016/0092-8674(92)90360-O |
0.308 |
|
| 1992 |
Inaba T, Matsushime H, Valentine M, Roussel MF, Sherr CJ, Look AT. Genomic organization, chromosomal localization, and independent expression of human cyclin D genes Genomics. 13: 565-574. PMID 1386335 DOI: 10.1016/0888-7543(92)90126-D |
0.316 |
|
| 1991 |
Matsushime H, Roussel MF, Ashmun RA, Sherr CJ. Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle Cell. 65: 701-713. PMID 1827757 DOI: 10.1016/0092-8674(91)90101-4 |
0.324 |
|
| 1991 |
Bortner DM, Ulivi M, Roussel MF, Ostrowski MC. The carboxy-terminal catalytic domain of the GTPase-activating protein inhibits nuclear signal transduction and morphological transformation mediated by the CSF-1 receptor. Genes & Development. 5: 1777-85. PMID 1717344 DOI: 10.1101/Gad.5.10.1777 |
0.309 |
|
| 1990 |
Roussel MF, Shurtleff SA, Downing JR, Sherr CJ. A point mutation at tyrosine-809 in the human colony-stimulating factor 1 receptor impairs mitogenesis without abrogating tyrosine kinase activity, association with phosphatidylinositol 3-kinase, or induction of c-fos and junB genes Proceedings of the National Academy of Sciences of the United States of America. 87: 6738-6742. PMID 2168557 DOI: 10.1073/Pnas.87.17.6738 |
0.318 |
|
| 1989 |
Roussel MF, Sherr CJ. Mouse NIH 3T3 cells expressing human colony-stimulating factor 1 (CSF-1) receptors overgrow in serum-free medium containing human CSF-1 as their only growth factor Proceedings of the National Academy of Sciences of the United States of America. 86: 7924-7927. PMID 2554296 DOI: 10.1073/Pnas.86.20.7924 |
0.324 |
|
| 1988 |
Roussel MF, Rettenmier CW, Sherr CJ. Introduction of a human colony stimulating factor-1 gene into a mouse macrophage cell line induces CSF-1 independence but not tumorigenicity Blood. 71: 1218-1225. PMID 3282567 DOI: 10.1182/Blood.V71.5.1218.Bloodjournal7151218 |
0.345 |
|
| 1988 |
Rettenmier CW, Roussel MF, Sherr CJ. The conoly-stimulating factor 1 (CSF-1) receptor (c-fms proto-oncogene product) and its ligand Journal of Cell Science. 27-44. PMID 2978516 DOI: 10.1242/Jcs.1988.Supplement_9.2 |
0.361 |
|
| 1988 |
Sherr CJ, Roussel MF, Rettenmier CW. Colony-stimulating factor-1 receptor (c-fms) Journal of Cellular Biochemistry. 38: 179-187. PMID 2852667 DOI: 10.1002/Jcb.240380305 |
0.32 |
|
| 1988 |
Roussel MF, Downing JR, Ashmun RA, Rettenmier CW, Sherr CJ. Colony-stimulating factor 1-mediated regulation of a chimeric c-fms/v-fms receptor containing the v-fms-encoded tyrosine kinase domain Proceedings of the National Academy of Sciences of the United States of America. 85: 5903-5907. PMID 2842754 DOI: 10.1073/Pnas.85.16.5903 |
0.324 |
|
| 1987 |
Rettenmier CW, Roussel MF, Ashmun RA, Ralph P, Price K, Sherr CJ. Synthesis of membrane-bound colony-stimulating factor 1 (CSF-1) and downmodulation of CSF-1 receptors in NIH 3T3 cells transformed by cotransfection of the human CSF-1 and c-fms (CSF-1 receptor) genes. Molecular and Cellular Biology. 7: 2378-87. PMID 3039346 DOI: 10.1128/Mcb.7.7.2378 |
0.311 |
|
| 1987 |
Roussel MF, Dull TJ, Rettenmier CW, Ralph P, Ullrich A, Sherr CJ. Transforming potential of the c-fms proto-oncogene (CSF-1 receptor). Nature. 325: 549-52. PMID 3027579 DOI: 10.1038/325549A0 |
0.301 |
|
| 1987 |
Heard JM, Roussel MF, Rettenmier CW, Sherr CJ. Multilineage hematopoietic disorders induced by transplantation of bone marrow cells expressing the v-fms oncogene Cell. 51: 663-673. PMID 2824063 DOI: 10.1016/0092-8674(87)90135-8 |
0.302 |
|
| 1985 |
Roussel MF, Rettenmier CW, Look AT, Sherr CJ. Cell surface expression of v-fms-coded glycoproteins is required for transformation. Molecular and Cellular Biology. 4: 1999-2009. PMID 6390182 DOI: 10.1128/Mcb.4.10.1999 |
0.307 |
|
| Show low-probability matches. |